Skip Navigation
  • May is ALS Awareness Month
    May is ALS Awareness Month!
  • FDA grants accelerated approval of tofersen for treatment of SOD1-ALS
    Drug’s development stemmed from collaborative research from Packard Center investigators.
  • Artificial intelligence-driven platform identifies new ALS gene targets
    Twenty-eight targets were identified, and the collaborative study was led by Insilico with support from Answer ALS and researchers at nine institutions including the Johns Hopkins University School of Medicine
  • The Pathway to Discovery and Hope for ALS Patients and Researchers: A massive biological genetic and clinical resource for ALS and neurodegenerative diseases.
    Massive Answer ALS resource paper is published in Nature Neuroscience.

What is ALS?

Amyotrophic lateral sclerosis (ALS), also known as called Lou Gehrig's, disease is a rapidly progressive, fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles.  The average life span from diagnosis is two to five years.  There is no cure.

Understanding ALS

Join the Family - Get Involved

You can make a difference. Tell us your story. Get involved. Make a Gift.
The hope is in the science.